{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:07:49Z","timestamp":1792724869198,"version":"4.5.0"},"reference-count":123,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41581-025-01038-w","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T10:02:14Z","timestamp":1767607334000},"page":"301-310","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Multifactorial chronic kidney disease and the kidney capacity\u2013workload balance"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1774-8088","authenticated-orcid":false,"given":"Paola","family":"Romagnani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1325-1194","authenticated-orcid":false,"given":"Juliana C. N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-2956","authenticated-orcid":false,"given":"Hans-Joachim","family":"Anders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"key":"1038_CR1","doi-asserted-by":"crossref","unstructured":"KDIGO 2024 Clinical Practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 105, S117\u2013S314 (2024).","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"1038_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41581-021-00510-7","volume":"18","author":"VA Luyckx","year":"2022","unstructured":"Luyckx, V. A. et al. Nephron overload as a therapeutic target to maximize kidney lifespan. Nat. Rev. Nephrol. 18, 171\u2013183 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41584-024-01158-w","volume":"20","author":"J Lichtnekert","year":"2024","unstructured":"Lichtnekert, J. & Anders, H. J. Lupus nephritis-related chronic kidney disease. Nat. Rev. Rheumatol. 20, 699\u2013711 (2024).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Prim. 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1038_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","volume":"404","author":"G Livingston","year":"2024","unstructured":"Livingston, G. et al. Dementia prevention, intervention, and care: 2024 report of the lancet standing commission. Lancet 404, 572\u2013628 (2024).","journal-title":"Lancet"},{"key":"1038_CR6","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","volume":"95","author":"KJ Rothman","year":"2005","unstructured":"Rothman, K. J. & Greenland, S. Causation and causal inference in epidemiology. Am. J. Public Health 95, S144\u2013S150 (2005).","journal-title":"Am. J. Public Health"},{"key":"1038_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03753-4","volume":"9","author":"E Lazzeri","year":"2018","unstructured":"Lazzeri, E. et al. Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. Nat. Commun. 9, 1344 (2018).","journal-title":"Nat. Commun."},{"key":"1038_CR8","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.molmed.2019.02.006","volume":"25","author":"E Lazzeri","year":"2019","unstructured":"Lazzeri, E., Angelotti, M. L., Conte, C., Anders, H. J. & Romagnani, P. Surviving acute organ failure: cell polyploidization and progenitor proliferation. Trends Mol. Med. 25, 366\u2013381 (2019).","journal-title":"Trends Mol. Med."},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000363721","volume":"127","author":"A Sharma","year":"2014","unstructured":"Sharma, A., Mucino, M. J. & Ronco, C. Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin. Pract. 127, 94\u2013100 (2014).","journal-title":"Nephron Clin. Pract."},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.kint.2022.02.039","volume":"102","author":"BM Klinkhammer","year":"2022","unstructured":"Klinkhammer, B. M. et al. Current kidney function parameters overestimate kidney tissue repair in reversible experimental kidney disease. Kidney Int. 102, 307\u2013320 (2022).","journal-title":"Kidney Int."},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-018-0001-y","volume":"14","author":"HJ Anders","year":"2018","unstructured":"Anders, H. J., Huber, T. B., Isermann, B. & Schiffer, M. CKD in diabetes: diabetic kidney disease versus nondiabetic kidney disease. Nat. Rev. Nephrol. 14, 361\u2013377 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.28701","volume":"5","author":"DS Gipson","year":"2022","unstructured":"Gipson, D. S. et al. Comparing kidney health outcomes in children, adolescents, and adults with focal segmental glomerulosclerosis. JAMA Netw. open. 5, e2228701 (2022).","journal-title":"JAMA Netw. open."},{"key":"1038_CR13","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/ndt\/gfae034","volume":"39","author":"S Abd ElHafeez","year":"2024","unstructured":"Abd ElHafeez, S. et al. Incidence and outcomes of kidney replacement therapy for end-stage kidney disease due to primary glomerular disease in Europe: findings from the ERA Registry. Nephrol. Dial. Transpl. 39, 1449\u20131460 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1038_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-01872-8","volume":"16","author":"G Bassanese","year":"2021","unstructured":"Bassanese, G. et al. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results. Orphanet J. Rare Dis. 16, 251 (2021).","journal-title":"Orphanet J. Rare Dis."},{"key":"1038_CR15","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(23)02843-X","volume":"403","author":"K Wong","year":"2024","unstructured":"Wong, K. et al. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National registry of rare kidney diseases (RaDaR) cohort. Lancet 403, 1279\u20131289 (2024).","journal-title":"Lancet"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"A8","DOI":"10.1053\/j.ajkd.2024.01.001","volume":"83","author":"KL Johansen","year":"2024","unstructured":"Johansen, K. L. et al. US renal data system 2023 annual data report: epidemiology of kidney disease in the United States. Am. J. Kidney Dis. 83, A8\u2013a13 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1053\/j.ajkd.2024.05.010","volume":"84","author":"N Franceschini","year":"2024","unstructured":"Franceschini, N. et al. Advancing genetic testing in kidney diseases: report from a national kidney foundation working group. Am. J. Kidney Dis. 84, 751\u2013766 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1053\/j.ajkd.2023.12.014","volume":"84","author":"A Itoku","year":"2024","unstructured":"Itoku, A., Isaac, J., Wilson, S., Reidy, K. & Kaskel, F. APOL1 nephropathy risk variants through the life course: a review. Am. J. Kidney Dis. 84, 102\u2013110 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR19","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa2404211","volume":"392","author":"RA Gbadegesin","year":"2025","unstructured":"Gbadegesin, R. A. et al. APOL1 Bi- and monoallelic variants and chronic kidney disease in West Africans. N. Engl. J. Med. 392, 228\u2013238 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5551\/jat.RV17026","volume":"26","author":"Y Yoshida","year":"2019","unstructured":"Yoshida, Y., Kato, H., Ikeda, Y. & Nangaku, M. Pathogenesis of atypical hemolytic uremic syndrome. J. Atheroscler. Thromb. 26, 99\u2013110 (2019).","journal-title":"J. Atheroscler. Thromb."},{"key":"1038_CR21","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1681\/ASN.2019080851","volume":"31","author":"S Chauvet","year":"2020","unstructured":"Chauvet, S. et al. Anti-Factor B antibodies and acute postinfectious GN in children. J. Am. Soc. Nephrol. 31, 829\u2013840 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR22","doi-asserted-by":"crossref","unstructured":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 102, S1\u2013S127 (2022).","DOI":"10.1016\/j.kint.2022.06.008"},{"key":"1038_CR23","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.kint.2019.12.002","volume":"97","author":"PK Li","year":"2020","unstructured":"Li, P. K. et al. Kidney health for everyone everywhere-from prevention to detection and equitable access to care. Kidney Int. 97, 226\u2013232 (2020).","journal-title":"Kidney Int."},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-024-00589-9","volume":"11","author":"P Romagnani","year":"2025","unstructured":"Romagnani, P. et al. Chronic kidney disease. Nat. Rev. Dis. Prim. 11, 8 (2025).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/nrneph.2014.251","volume":"11","author":"VA Luyckx","year":"2015","unstructured":"Luyckx, V. A. & Brenner, B. M. Birth weight, malnutrition and kidney-associated outcomes-a global concern. Nat. Rev. Nephrol. 11, 135\u2013149 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00467-011-1843-8","volume":"26","author":"JF Bertram","year":"2011","unstructured":"Bertram, J. F., Douglas-Denton, R. N., Diouf, B., Hughson, M. D. & Hoy, W. E. Human nephron number: implications for health and disease. Pediatr. Nephrol. 26, 1529\u20131533 (2011).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1681\/ASN.2020040449","volume":"31","author":"A Denic","year":"2020","unstructured":"Denic, A. et al. Larger nephron size and nephrosclerosis predict progressive CKD and mortality after radical nephrectomy for tumor and independent of kidney function. J. Am. Soc. Nephrol. 31, 2642\u20132652 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1056\/NEJMoa1614329","volume":"376","author":"A Denic","year":"2017","unstructured":"Denic, A. et al. Single-nephron glomerular filtration rate in healthy adults. N. Engl. J. Med. 376, 2349\u20132357 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1681\/ASN.2016020154","volume":"28","author":"A Denic","year":"2017","unstructured":"Denic, A. et al. The substantial loss of nephrons in healthy human kidneys with aging. J. Am. Soc. Nephrol. 28, 313\u2013320 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41581-022-00559-y","volume":"18","author":"M Cortinovis","year":"2022","unstructured":"Cortinovis, M., Perico, N., Ruggenenti, P., Remuzzi, A. & Remuzzi, G. Glomerular hyperfiltration. Nat. Rev. Nephrol. 18, 435\u2013451 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","volume":"11","author":"NR Hill","year":"2016","unstructured":"Hill, N. R. et al. Global prevalence of chronic kidney disease \u2014 a systematic review and meta-analysis. PLoS ONE 11, e0158765 (2016).","journal-title":"PLoS ONE"},{"key":"1038_CR32","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","volume":"18","author":"D Pitcher","year":"2023","unstructured":"Pitcher, D. et al. Long-term outcomes in IgA nephropathy. Clin. J. Am. Soc. Nephrol. 18, 727\u2013738 (2023).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1038_CR33","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/ki.2011.379","volume":"81","author":"SG Coca","year":"2012","unstructured":"Coca, S. G., Singanamala, S. & Parikh, C. R. Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney Int. 81, 442\u2013448 (2012).","journal-title":"Kidney Int."},{"key":"1038_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41581-025-00932-7","volume":"21","author":"E Vidal","year":"2025","unstructured":"Vidal, E. & Trevisanuto, D. Born too soon: lifelong kidney risks and the importance of early intervention. Nat. Rev. Nephrol. 21, 151\u2013152 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR35","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S0140-6736(17)30576-7","volume":"390","author":"VA Luyckx","year":"2017","unstructured":"Luyckx, V. A. et al. A developmental approach to the prevention of hypertension and kidney disease: a report from the low birth weight and nephron number working group. Lancet 390, 424\u2013428\u00a0(2017).","journal-title":"Lancet"},{"key":"1038_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1053\/j.ajkd.2017.06.030","volume":"71","author":"JG Eriksson","year":"2018","unstructured":"Eriksson, J. G., Salonen, M. K., Kajantie, E. & Osmond, C. Prenatal growth and CKD in older adults: longitudinal findings from the Helsinki birth cohort study, 1924\u20131944. Am. J. Kidney Dis. 71, 20\u201326 (2018).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR37","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.2215\/CJN.04080320","volume":"15","author":"A Gjerde","year":"2020","unstructured":"Gjerde, A., Reis\u00e6ter, A. V., Skrunes, R., Marti, H. P. & Vikse, B. E. Intrauterine Growth restriction and risk of diverse forms of kidney disease during the first 50 years of life. Clin. J. Am. Soc. Nephrol. 15, 1413\u20131423 (2020).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1038_CR38","doi-asserted-by":"publisher","first-page":"F21","DOI":"10.1152\/ajprenal.00383.2023","volume":"327","author":"Z Oulerich","year":"2024","unstructured":"Oulerich, Z. & Sferruzzi-Perri, A. N. Early-life exposures and long-term health: adverse gestational environments and the programming of offspring renal and vascular disease. Am. J. Physiol. Renal Physiol. 327, F21\u2013f36 (2024).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"1038_CR39","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1053\/j.ajkd.2006.11.031","volume":"49","author":"DA Shoham","year":"2007","unstructured":"Shoham, D. A. et al. Kidney disease in life-course socioeconomic context: the Atherosclerosis risk in communities (ARIC) Study. Am. J. Kidney Dis. 49, 217\u2013226 (2007).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR40","doi-asserted-by":"publisher","first-page":"l1346","DOI":"10.1136\/bmj.l1346","volume":"365","author":"C Crump","year":"2019","unstructured":"Crump, C., Sundquist, J., Winkleby, M. A. & Sundquist, K. Preterm birth and risk of chronic kidney disease from childhood into mid-adulthood: national cohort study. BMJ 365, l1346 (2019).","journal-title":"BMJ"},{"key":"1038_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.semnephrol.2017.05.002","volume":"37","author":"VA Luyckx","year":"2017","unstructured":"Luyckx, V. A. Preterm birth and its impact on renal health. Semin. Nephrol. 37, 311\u2013319 (2017).","journal-title":"Semin. Nephrol."},{"key":"1038_CR42","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.kint.2023.05.013","volume":"104","author":"KU Eckardt","year":"2023","unstructured":"Eckardt, K. U. et al. Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 104, 888\u2013903 (2023).","journal-title":"Kidney Int."},{"key":"1038_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.43146","volume":"5","author":"R Mohr Lytsen","year":"2022","unstructured":"Mohr Lytsen, R. et al. Markers of kidney function in early childhood and association with maternal comorbidity. JAMA Netw. open. 5, e2243146 (2022).","journal-title":"JAMA Netw. open."},{"key":"1038_CR44","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41572-023-00417-6","volume":"9","author":"E Dimitriadis","year":"2023","unstructured":"Dimitriadis, E. et al. Pre-eclampsia. Nat. Rev. Dis. Prim. 9, 8 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1038_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/JPN.0000000000000024","volume":"28","author":"CA Botwinski","year":"2014","unstructured":"Botwinski, C. A. & Falco, G. A. Transition to postnatal renal function. J. Perinat. Neonatal Nurs. 28, 150\u2013154, e153-154 (2014).","journal-title":"J. Perinat. Neonatal Nurs."},{"key":"1038_CR46","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1053\/j.sempedsurg.2013.10.008","volume":"22","author":"M Sulemanji","year":"2013","unstructured":"Sulemanji, M. & Vakili, K. Neonatal renal physiology. Semin. Pediatr. Surg. 22, 195\u2013198 (2013).","journal-title":"Semin. Pediatr. Surg."},{"key":"1038_CR47","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3390\/children12030339","volume":"12","author":"E Staub","year":"2025","unstructured":"Staub, E., Bolisetty, S., Allegaert, K. & Raaijmakers, A. Neonatal kidney function, injury and drug dosing: a contemporary review. Children 12, 339 (2025).","journal-title":"Children"},{"key":"1038_CR48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1159\/000513666","volume":"118","author":"D Gallo","year":"2021","unstructured":"Gallo, D., de Bijl-Marcus, K. A., Alderliesten, T., Lilien, M. & Groenendaal, F. Early acute kidney injury in preterm and term neonates: incidence, outcome, and associated clinical features. Neonatology 118, 174\u2013179 (2021).","journal-title":"Neonatology"},{"key":"1038_CR49","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1007\/s00467-025-06757-7","volume":"40","author":"KT Vuong","year":"2025","unstructured":"Vuong, K. T. et al. Expanded discussion of kidney health monitoring for critically ill term and late preterm infants after acute kidney injury: a report from the neonatal kidney health consensus workshop. Pediatr. Nephrol. 40, 2993\u20133004 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR50","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1007\/s00467-018-3966-7","volume":"33","author":"MA Shalaby","year":"2018","unstructured":"Shalaby, M. A. et al. Incidence, risk factors, and outcome of neonatal acute kidney injury: a prospective cohort study. Pediatr. Nephrol. 33, 1617\u20131624 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33110-5","volume":"13","author":"L De Chiara","year":"2022","unstructured":"De Chiara, L. et al. Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease. Nat. Commun. 13, 5805 (2022).","journal-title":"Nat. Commun."},{"key":"1038_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2025.106222","volume":"202","author":"K Vivek","year":"2025","unstructured":"Vivek, K. et al. Fetal bilateral hyperechogenic kidneys: prenatal progression and long-term postnatal outcome. Early Hum. Dev. 202, 106222 (2025).","journal-title":"Early Hum. Dev."},{"key":"1038_CR53","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1007\/s00467-020-04712-2","volume":"36","author":"LA Hoogenboom","year":"2021","unstructured":"Hoogenboom, L. A., Wolfs, T., H\u00fctten, M. C., Peutz-Kootstra, C. J. & Schreuder, M. F. Prematurity, perinatal inflammatory stress, and the predisposition to develop chronic kidney disease beyond oligonephropathy. Pediatr. Nephrol. 36, 1673\u20131681 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR54","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s13730-024-00931-w","volume":"14","author":"C Onodera","year":"2025","unstructured":"Onodera, C. et al. Chronic kidney disease associated with extremely premature birth and extremely low birth weight may progress through the burden of growth. CEN Case Rep. 14, 224\u2013229 (2025).","journal-title":"CEN Case Rep."},{"key":"1038_CR55","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ckj\/sfw047","volume":"9","author":"F Becherucci","year":"2016","unstructured":"Becherucci, F., Roperto, R. M., Materassi, M. & Romagnani, P. Chronic kidney disease in children. Clin. Kidney J. 9, 583\u2013591 (2016).","journal-title":"Clin. Kidney J."},{"key":"1038_CR56","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/ndt\/gfad207","volume":"39","author":"CM Baker-Smith","year":"2024","unstructured":"Baker-Smith, C. M. & Flynn, J. T. 2023 European pediatric hypertension guidelines: has anything changed?. Nephrol. Dial. Transpl. 39, 382\u2013384 (2024).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1038_CR57","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2215\/CJN.05210515","volume":"11","author":"TK Mattoo","year":"2016","unstructured":"Mattoo, T. K. et al. Renal scarring in the randomized intervention for children with vesicoureteral reflux (RIVUR) Trial. Clin. J. Am. Soc. Nephrol. 11, 54\u201361 (2016).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1038_CR58","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00467-020-04573-9","volume":"36","author":"I Hewitt","year":"2021","unstructured":"Hewitt, I. & Montini, G. Vesicoureteral reflux is it important to find?. Pediatr. Nephrol. 36, 1011\u20131017 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR59","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.3399\/bjgp24X739053","volume":"74","author":"K Hughes","year":"2024","unstructured":"Hughes, K. et al. Long-term consequences of urinary tract infection in childhood: an electronic population-based cohort study in Welsh primary and secondary care. Br. J. Gen. Pract. 74, e371\u2013e378 (2024).","journal-title":"Br. J. Gen. Pract."},{"key":"1038_CR60","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.3390\/biomedicines12112582","volume":"12","author":"S Maringhini","year":"2024","unstructured":"Maringhini, S., Alaygut, D. & Corrado, C. Urinary tract infection in children: an up-to-date study. Biomedicines 12, 2582 (2024).","journal-title":"Biomedicines"},{"key":"1038_CR61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00467-024-06586-0","volume":"40","author":"EH Ulrich","year":"2025","unstructured":"Ulrich, E. H. et al. Kidney and blood pressure outcomes 11 years after pediatric critical illness and longitudinal impact of AKI: a prospective cohort study. Pediatr. Nephrol. 40, 1111\u20131120 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR62","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1681\/ASN.0000000000000445","volume":"35","author":"CH Robinson","year":"2024","unstructured":"Robinson, C. H. et al. Long-term kidney outcomes after pediatric acute kidney injury. J. Am. Soc. Nephrol. 35, 1520\u20131532\u00a0(2024).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR63","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00467-008-1074-9","volume":"24","author":"SP Andreoli","year":"2009","unstructured":"Andreoli, S. P. Acute kidney injury in children. Pediatr. Nephrol. 24, 253\u2013263 (2009).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s00467-024-06366-w","volume":"40","author":"LF Alconcher","year":"2025","unstructured":"Alconcher, L. F., Lucarelli, L. I., Bronfen, S., Meni Battaglia, L. & Balestracci, A. Dynamic evolution of kidney function in patients with STEC-hemolytic uremic syndrome followed for more than 15 years: unexpected changes. Pediatr. Nephrol. 40, 143\u2013150 (2025).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR65","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3390\/ijms22020905","volume":"22","author":"T Oda","year":"2021","unstructured":"Oda, T. & Yoshizawa, N. Factors affecting the progression of infection-related glomerulonephritis to chronic kidney disease. Int. J. Mol. Sci. 22, 905 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1038_CR66","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.969456","volume":"13","author":"SY Wang","year":"2022","unstructured":"Wang, S. Y., Gao, J. & Zhao, J. H. Effects of high altitude on renal physiology and kidney diseases. Front. Physiol. 13, 969456 (2022).","journal-title":"Front. Physiol."},{"key":"1038_CR67","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/bcp.12554","volume":"80","author":"LN Faught","year":"2015","unstructured":"Faught, L. N., Greff, M. J., Rieder, M. J. & Koren, G. Drug-induced acute kidney injury in children. Br. J. Clin. Pharmacol. 80, 901\u2013909 (2015).","journal-title":"Br. J. Clin. Pharmacol."},{"key":"1038_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00467-017-3662-z","volume":"33","author":"R Skinner","year":"2018","unstructured":"Skinner, R. Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance. Pediatr. Nephrol. 33, 215\u2013225 (2018).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR69","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1093\/ckj\/sfab056","volume":"14","author":"R Torra","year":"2021","unstructured":"Torra, R., Furlano, M., Ortiz, A. & Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clin. Kidney J. 14, 1879\u20131885 (2021).","journal-title":"Clin. Kidney J."},{"key":"1038_CR70","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00467-020-04553-z","volume":"36","author":"PM Ekulu","year":"2021","unstructured":"Ekulu, P. M. et al. A focus on the association of Apol1 with kidney disease in children. Pediatr. Nephrol. 36, 777\u2013788 (2021).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR71","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41581-022-00540-9","volume":"18","author":"KI Ataga","year":"2022","unstructured":"Ataga, K. I., Saraf, S. L. & Derebail, V. K. The nephropathy of sickle cell trait and sickle cell disease. Nat. Rev. Nephrol. 18, 361\u2013377 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR72","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","volume":"405","author":"GBD 2021 Adolescent BMI Collaborators","year":"2025","unstructured":"GBD 2021 Adolescent BMI Collaborators Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021. Lancet 405, 785\u2013812 (2025).","journal-title":"Lancet"},{"key":"1038_CR73","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1093\/ckj\/sfac233","volume":"16","author":"G Mangat","year":"2023","unstructured":"Mangat, G. et al. Obesity-related glomerulopathy in children: connecting pathophysiology to clinical care. Clin. Kidney J. 16, 611\u2013618 (2023).","journal-title":"Clin. Kidney J."},{"key":"1038_CR74","doi-asserted-by":"publisher","first-page":"4744","DOI":"10.3390\/ijms21134744","volume":"21","author":"S Borrelli","year":"2020","unstructured":"Borrelli, S. et al. Sodium Intake and Chronic Kidney Disease. Int. J. Mol. Sci. 21, 4744 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1038_CR75","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s00467-022-05689-w","volume":"38","author":"G Rivetti","year":"2023","unstructured":"Rivetti, G., Hursh, B. E., Miraglia Del Giudice, E. & Marzuillo, P. Acute and chronic kidney complications in children with type 1 diabetes mellitus. Pediatr. Nephrol. 38, 1449\u20131458 (2023).","journal-title":"Pediatr. Nephrol."},{"key":"1038_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1389342","volume":"15","author":"P Sun","year":"2024","unstructured":"Sun, P. et al. Global burden of chronic kidney disease in adolescents and young adults, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Front. Endocrinol. 15, 1389342 (2024).","journal-title":"Front. Endocrinol."},{"key":"1038_CR77","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1053\/j.ajkd.2015.07.019","volume":"67","author":"TL McGregor","year":"2016","unstructured":"McGregor, T. L. et al. Acute kidney injury incidence in noncritically Ill hospitalized children, adolescents, and young adults: a retrospective observational study. Am. J. Kidney Dis. 67, 384\u2013390 (2016).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR78","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/ki.2009.462","volume":"77","author":"UH Beier","year":"2010","unstructured":"Beier, U. H., Green, C. & Meyers, K. E. Caring for adolescent renal patients. Kidney Int. 77, 285\u2013291 (2010).","journal-title":"Kidney Int."},{"key":"1038_CR79","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/nu15010097","volume":"15","author":"A P\u00e9rez-Torres","year":"2022","unstructured":"P\u00e9rez-Torres, A., Caverni-Mu\u00f1oz, A. & Gonz\u00e1lez Garc\u00eda, E. Mediterranean diet and chronic kidney disease (CKD): a practical approach. Nutrients 15, 97 (2022).","journal-title":"Nutrients"},{"key":"1038_CR80","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1681\/ASN.2005060638","volume":"17","author":"E Ejerblad","year":"2006","unstructured":"Ejerblad, E. et al. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrol. 17, 1695\u20131702 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR81","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41581-025-00977-8","volume":"21","author":"GB Piccoli","year":"2025","unstructured":"Piccoli, G. B. et al. Kidney health outcomes of hypertensive disorders of pregnancy. Nat. Rev. Nephrol. 21, 671\u2013686 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR82","doi-asserted-by":"publisher","DOI":"10.1016\/j.cotox.2022.100360","volume":"32","author":"JP Silva","year":"2022","unstructured":"Silva, J. P., Carmo, H. & Carvalho, F. Drugs of abuse and kidney toxicity. Curr. Opin. Toxicol. 32, 100360 (2022).","journal-title":"Curr. Opin. Toxicol."},{"key":"1038_CR83","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-021-00284-z","volume":"7","author":"JA Kellum","year":"2021","unstructured":"Kellum, J. A. et al. Acute kidney injury. Nat. Rev. Dis. Prim. 7, 52 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1038_CR84","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1053\/j.ackd.2020.07.006","volume":"27","author":"K Beers","year":"2020","unstructured":"Beers, K. & Patel, N. Kidney physiology in pregnancy. Adv. Chronic Kidney Dis. 27, 449\u2013454 (2020).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"1038_CR85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/jesnt.jesnt_32_19","volume":"19","author":"MA Gawad","year":"2019","unstructured":"Gawad, M. A. & Kalawy, H. A. Gym nephropathy \u2018bodybuilding versus kidney damaging. J. Egypt. Soc. Nephrol. Transpl. 19, 124\u2013128 (2019).","journal-title":"J. Egypt. Soc. Nephrol. Transpl."},{"key":"1038_CR86","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.nefro.2019.06.003","volume":"40","author":"SLA Parente Filho","year":"2020","unstructured":"Parente Filho, S. L. A. et al. Kidney disease associated with androgenic-anabolic steroids and vitamin supplements abuse: be aware! Nefrologia 40, 26\u201331 (2020).","journal-title":"Nefrologia"},{"key":"1038_CR87","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1093\/ntr\/ntaa071","volume":"23","author":"S Lee","year":"2021","unstructured":"Lee, S. et al. Smoking, smoking cessation, and progression of chronic kidney disease: results from KNOW-CKD study. Nicotine Tob. Res. 23, 92\u201398 (2021).","journal-title":"Nicotine Tob. Res."},{"key":"1038_CR88","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.26230","volume":"6","author":"CD Chu","year":"2023","unstructured":"Chu, C. D. et al. Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease. JAMA Netw. Open 6, e2326230 (2023).","journal-title":"JAMA Netw. Open"},{"key":"1038_CR89","unstructured":"Patel, J. B., Sapra, A. in StatPearls. (StatPearls, 2023)."},{"key":"1038_CR90","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1681\/ASN.2022020135","volume":"33","author":"JI Shin","year":"2022","unstructured":"Shin, J. I. et al. Association of rosuvastatin use with risk of hematuria and proteinuria. J. Am. Soc. Nephrol. 33, 1767\u20131777 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1038_CR91","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s40801-024-00426-1","volume":"11","author":"Y Sobukawa","year":"2024","unstructured":"Sobukawa, Y., Hatta, T., Funaki, D. & Nakatani, E. Safety of combined statin and fibrate therapy: risks of liver injury and acute kidney injury in a cohort study from the Shizuoka Kokuho database. Drugs Real World Outcomes 11, 317\u2013330 (2024).","journal-title":"Drugs Real World Outcomes"},{"key":"1038_CR92","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.2215\/CJN.11571017","volume":"13","author":"B Yang","year":"2018","unstructured":"Yang, B. et al. Nephrotoxicity and Chinese herbal medicine. Clin. J. Am. Soc. Nephrol. 13, 1605\u20131611 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1038_CR93","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288\u2013298 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1038_CR94","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1038\/s42255-024-01088-7","volume":"6","author":"O CK","year":"2024","unstructured":"CK, O. & Chan, J. C. N. Insights into optimal BMI from the GlasVEGAS study. Nat. Metab. 6, 1435\u20131437 (2024).","journal-title":"Nat. Metab."},{"key":"1038_CR95","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/S2213-8587(24)00157-8","volume":"12","author":"R Taylor","year":"2024","unstructured":"Taylor, R. Understanding the cause of type 2 diabetes. lancet Diabetes Endocrinol. 12, 664\u2013673 (2024).","journal-title":"lancet Diabetes Endocrinol."},{"key":"1038_CR96","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1053\/j.ajkd.2008.03.003","volume":"52","author":"MC Foster","year":"2008","unstructured":"Foster, M. C. et al. Overweight, obesity, and the development of stage 3 CKD: the Framingham Heart Study. Am. J. Kidney Dis. 52, 39\u201348 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR97","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele, C. E. et al. Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association. Circulation 148, 1606\u20131635 (2023).","journal-title":"Circulation"},{"key":"1038_CR98","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group","year":"2022","unstructured":"Nuffield Department of Population Health Renal Studies Group Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials. Lancet 400, 1788\u20131801 (2022).","journal-title":"Lancet"},{"key":"1038_CR99","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1093\/ndt\/gfaf068","volume":"40","author":"A Ortiz","year":"2025","unstructured":"Ortiz, A. et al. Maintaining kidney health in aging societies: a JSN and ERA call to action. Nephrol. Dial. Transpl. 40, 1498\u20131511\u00a0(2025).","journal-title":"Nephrol. Dial. Transpl."},{"key":"1038_CR100","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.kint.2023.10.036","volume":"105","author":"L De Chiara","year":"2024","unstructured":"De Chiara, L., Lazzeri, E. & Romagnani, P. Polyploid tubular cells: a shortcut to stress adaptation. Kidney Int. 105, 709\u2013716 (2024).","journal-title":"Kidney Int."},{"key":"1038_CR101","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jhep.2024.03.043","volume":"81","author":"K Yin","year":"2024","unstructured":"Yin, K. et al. Polyploidisation pleiotropically buffers ageing in hepatocytes. J. Hepatol. 81, 289\u2013302 (2024).","journal-title":"J. Hepatol."},{"key":"1038_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93912-3","volume":"11","author":"Z Dimitrijevic","year":"2021","unstructured":"Dimitrijevic, Z., Paunovic, G., Tasic, D., Mitic, B. & Basic, D. Risk factors for urosepsis in chronic kidney disease patients with urinary tract infections. Sci. Rep. 11, 14414 (2021).","journal-title":"Sci. Rep."},{"key":"1038_CR103","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/s41581-024-00823-3","volume":"20","author":"RK Hall","year":"2024","unstructured":"Hall, R. K. et al. Drug stewardship in chronic kidney disease to achieve effective and safe medication use. Nat. Rev. Nephrol. 20, 386\u2013401 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR104","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","volume":"14","author":"JA Batsis","year":"2018","unstructured":"Batsis, J. A. & Villareal, D. T. Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies. Nat. Rev. Endocrinol. 14, 513\u2013537 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1038_CR105","doi-asserted-by":"publisher","first-page":"S111","DOI":"10.2337\/dc24-S006","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee 6. Glycemic Goals and Hypoglycemia: standards of care in diabetes-2024. Diabetes Care 47, S111\u2013S125 (2024).","journal-title":"Diabetes Care"},{"key":"1038_CR106","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41581-025-00931-8","volume":"21","author":"MF Blum","year":"2025","unstructured":"Blum, M. F., Neuen, B. L. & Grams, M. E. Risk-directed management of chronic kidney disease. Nat. Rev. Nephrol. 21, 287\u2013298 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR107","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12882-025-03944-4","volume":"26","author":"L Cheng","year":"2025","unstructured":"Cheng, L., Hu, N., Song, D., Liu, L. & Chen, Y. Early versus late nephrology referral and patient outcomes in chronic kidney disease: an updated systematic review and meta-analysis. BMC Nephrol. 26, 25 (2025).","journal-title":"BMC Nephrol."},{"key":"1038_CR108","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ekir.2022.01.1066","volume":"7","author":"JA Vassalotti","year":"2022","unstructured":"Vassalotti, J. A. & Boucree, S. C. Integrating CKD Into US primary care: bridging the knowledge and implementation gaps. Kidney Int. Rep. 7, 389\u2013396 (2022).","journal-title":"Kidney Int. Rep."},{"key":"1038_CR109","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.2215\/CJN.12101116","volume":"12","author":"S Park","year":"2017","unstructured":"Park, S. et al. Midterm eGFR and adverse pregnancy outcomes: the clinical significance of gestational Hyperfiltration. Clin. J. Am. Soc. Nephrol. 12, 1048\u20131056 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1038_CR110","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/phe\/phad017","volume":"16","author":"T Schramme","year":"2023","unstructured":"Schramme, T. Health as complete well-being: the WHO definition and beyond. Public. Health Ethics 16, 210\u2013218 (2023).","journal-title":"Public. Health Ethics"},{"key":"1038_CR111","doi-asserted-by":"publisher","first-page":"3810","DOI":"10.4103\/jfmpc.jfmpc_1264_19","volume":"9","author":"R Pal","year":"2020","unstructured":"Pal, R., Rathore, V., Galhotra, A. & Mamidi, V. Chronic kidney diseases: a realm for preventive nephrology. J. Fam. Med. Prim. Care 9, 3810\u20133814 (2020).","journal-title":"J. Fam. Med. Prim. Care"},{"key":"1038_CR112","doi-asserted-by":"publisher","first-page":"567","DOI":"10.7326\/0003-4819-157-8-201210160-00533","volume":"157","author":"VA Moyer","year":"2012","unstructured":"Moyer, V. A.U.S. Preventive Services Task Force Screening for chronic kidney disease: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 157, 567\u2013570 (2012).","journal-title":"Ann. Intern. Med."},{"key":"1038_CR113","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.ekir.2019.06.004","volume":"4","author":"N Kamath","year":"2019","unstructured":"Kamath, N., Iyengar, A., George, N. & Luyckx, V. A. Risk factors and rate of progression of CKD in children. Kidney Int. Rep. 4, 1472\u20131477 (2019).","journal-title":"Kidney Int. Rep."},{"key":"1038_CR114","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1007\/s00125-021-05494-4","volume":"64","author":"H Wu","year":"2021","unstructured":"Wu, H. et al. Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study. Diabetologia 64, 1990\u20132000 (2021).","journal-title":"Diabetologia"},{"key":"1038_CR115","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2213-8587(23)00225-5","volume":"11","author":"S Misra","year":"2023","unstructured":"Misra, S. et al. Current insights and emerging trends in early-onset type 2 diabetes. Lancet Diabetes Endocrinol. 11, 768\u2013782 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"1038_CR116","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1001\/jama.2024.2252","volume":"331","author":"D Mozaffarian","year":"2024","unstructured":"Mozaffarian, D. GLP-1 agonists for obesity-a new recipe for success? JAMA 331, 1007\u20131008 (2024).","journal-title":"JAMA"},{"key":"1038_CR117","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41581-021-00534-z","volume":"18","author":"PJ Schulz","year":"2022","unstructured":"Schulz, P. J. & Nakamoto, K. The perils of misinformation: when health literacy goes awry. Nat. Rev. Nephrol. 18, 135\u2013136 (2022).","journal-title":"Nat. Rev. Nephrol."},{"key":"1038_CR118","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.kint.2022.12.013","volume":"103","author":"LL Hsiao","year":"2023","unstructured":"Hsiao, L. L. et al. Kidney health for all: preparedness for the unexpected in supporting the vulnerable. Kidney Int. 103, 436\u2013443 (2023).","journal-title":"Kidney Int."},{"key":"1038_CR119","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","volume":"396","author":"JCN Chan","year":"2021","unstructured":"Chan, J. C. N. et al. The Lancet commission on diabetes: using data to transform diabetes care and patient lives. Lancet 396, 2019\u20132082 (2021).","journal-title":"Lancet"},{"key":"1038_CR120","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/ije\/2.3.221","volume":"2","author":"JM Weddell","year":"1973","unstructured":"Weddell, J. M. Registers and registries: a review. Int. J. Epidemiol. 2, 221\u2013228 (1973).","journal-title":"Int. J. Epidemiol."},{"key":"1038_CR121","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1053\/j.ajkd.2023.08.015","volume":"83","author":"TM El-Achkar","year":"2024","unstructured":"El-Achkar, T. M., Eadon, M. T., Kretzler, M. & Himmelfarb, J. Precision medicine in nephrology: an integrative framework of multidimensional data in the kidney precision medicine project. Am. J. Kidney Dis. 83, 402\u2013410 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1038_CR122","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2337\/dca24-0069","volume":"48","author":"ESH Lau","year":"2025","unstructured":"Lau, E. S. H. et al. Development and validation of the patient-level Chinese diabetes outcome model on long-term complications in type 2 diabetes: an application of the Hong Kong diabetes register. Diabetes Care 48, 579\u2013587 (2025).","journal-title":"Diabetes Care"},{"key":"1038_CR123","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1093\/ndt\/gfaf092","volume":"40","author":"J Halbritter","year":"2025","unstructured":"Halbritter, J. et al. Chronic kidney disease of unexplained cause (CKDx): a consensus statement by the genes & kidney working group of the ERA. Nephrol. Dial. Transpl. 40, 2390\u20132400\u00a0(2025).","journal-title":"Nephrol. Dial. Transpl."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01038-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01038-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01038-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T13:01:46Z","timestamp":1774270906000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-025-01038-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":123,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1038\/s41581-025-01038-w","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"20 November 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.C.N.C. reports receiving grants (through institutions) and\/or honoraria for consultancy or giving lectures from Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Celltrion, Eli Lilly, Hua Medicine, Powder Pharmaceuticals, Roche, Merck, MSD, Pfizer, Sanofi, Servier, Viatris and Zuellig Therapeutics. She is the co-founder of GemVCare, a technology company, with partial support from the Hong Kong Government, which uses biogenetic markers and information technology to implement precision diabetes care and prevention through partnerships. J.C.N.C. is the chief executive officer (pro bono) of the Asia Diabetes Foundation, which developed the web-based JADE platform for implementation of data-driven diabetes care. She is a member of the Global Council of the European Association for Study of Diabetes and a member of the International Diabetes Federation Global Guidelines for type 2 diabetes and member of working groups of Kidney Disease Improving Global Outcomes (KDIGO). H.J.A. received payments from the European Renal Association for his role as editor-in-chief of\n                      Nephrology Dialysis Transplantation\n                      . H.J.A. is a member of the Western-European Regional board of the International Society of Nephrology (ISN). Related to the content of this paper, H.J.A. received funding from Boehringer-Ingelheim and consultancy fees from Novartis, AstraZeneca, Bayer, Boehringer-Ingelheim, Vifor, Otsuka, Roche, Lilly. P.R. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}